These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14982770)

  • 1. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma.
    Stone JA; Xu X; Winchell GA; Deutsch PJ; Pearson PG; Migoya EM; Mistry GC; Xi L; Miller A; Sandhu P; Singh R; deLuna F; Dilzer SC; Lasseter KC
    Antimicrob Agents Chemother; 2004 Mar; 48(3):815-23. PubMed ID: 14982770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys.
    Sandhu P; Xu X; Bondiskey PJ; Balani SK; Morris ML; Tang YS; Miller AR; Pearson PG
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1272-80. PubMed ID: 15047529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872).
    Hajdu R; Thompson R; Sundelof JG; Pelak BA; Bouffard FA; Dropinski JF; Kropp H
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2339-44. PubMed ID: 9371330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
    Stone JA; Holland SD; Wickersham PJ; Sterrett A; Schwartz M; Bonfiglio C; Hesney M; Winchell GA; Deutsch PJ; Greenberg H; Hunt TL; Waldman SA
    Antimicrob Agents Chemother; 2002 Mar; 46(3):739-45. PubMed ID: 11850256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.
    Balani SK; Xu X; Arison BH; Silva MV; Gries A; DeLuna FA; Cui D; Kari PH; Ly T; Hop CE; Singh R; Wallace MA; Dean DC; Lin JH; Pearson PG; Baillie TA
    Drug Metab Dispos; 2000 Nov; 28(11):1274-8. PubMed ID: 11038152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits.
    Groll AH; Gullick BM; Petraitiene R; Petraitis V; Candelario M; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):596-600. PubMed ID: 11158761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for interactions between caspofungin and nelfinavir or rifampin.
    Stone JA; Migoya EM; Hickey L; Winchell GA; Deutsch PJ; Ghosh K; Freeman A; Bi S; Desai R; Dilzer SC; Lasseter KC; Kraft WK; Greenberg H; Waldman SA
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4306-14. PubMed ID: 15504857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers.
    Bekersky I; Fielding RM; Dressler DE; Kline S; Buell DN; Walsh TJ
    J Clin Pharmacol; 2001 Sep; 41(9):963-71. PubMed ID: 11549101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants.
    Migoya EM; Mistry GC; Stone JA; Comisar W; Sun P; Norcross A; Bi S; Winchell GA; Ghosh K; Uemera N; Deutsch PJ; Wagner JA
    J Clin Pharmacol; 2011 Feb; 51(2):202-11. PubMed ID: 20679501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.
    Louie A; Deziel M; Liu W; Drusano MF; Gumbo T; Drusano GL
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5058-68. PubMed ID: 16304173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilofungin (LY121019) shows nonlinear plasma pharmacokinetics and tissue penetration in rabbits.
    Lee JW; Kelly P; Lecciones J; Coleman D; Gordee R; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2240-5. PubMed ID: 2073114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.
    Petraitiene R; Petraitis V; Groll AH; Sein T; Schaufele RL; Francesconi A; Bacher J; Avila NA; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jan; 46(1):12-23. PubMed ID: 11751105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
    Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
    J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs.
    Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y
    Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic uptake of the novel antifungal agent caspofungin.
    Sandhu P; Lee W; Xu X; Leake BF; Yamazaki M; Stone JA; Lin JH; Pearson PG; Kim RB
    Drug Metab Dispos; 2005 May; 33(5):676-82. PubMed ID: 15716364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.